< Back to previous page
Organisation
Department of Pharmaceutics
Department
Main organisation:Faculty of Pharmaceutical Sciences
Lifecycle:1 Jan 1993 → Today
Organisation profile:The department consists of four departments: laboratory of pharmaceutical technology, laboratory of general biochemistry and physical pharmacy, laboratory of pharmaceutical biotechnology, laboratory of medicinal chemistry
Keywords:Geneesmiddelenleer
Disciplines:Medicinal products, Drug discovery and development
Current researchers
1 - 10 of 163 results
- Justine Aelvoet (Member)
- Ilke Aernout (Member)
- Amin Ahmad (Member)
- Mohsin Ali (Member)
- Ruben Almey (Member)
- Léo Baland (Member)
- Margaux Bauwens (Member)
- Dominika Berdecka (Member)
- Danique Berrevoet (Member)
Projects
1 - 10 of 455
- High-Precision Mapping of HLA Gene Links to Clozapine-Induced Neutropenia via Long-Read Amplicon Sequencing with Double UMIsFrom1 Mar 2026 → TodayFunding: BOF - doctoral mandates
- Image analysis platform for users of the GLiM core facilityFrom1 Dec 2025 → TodayFunding: BOF - scientific equipment program
- High-Throughput, Cost-Efficient NGS Library Preparation Using 384-Well Infrastructure at the UGent NGS CoreFrom1 Dec 2025 → TodayFunding: BOF - scientific equipment program
- Laser-Scanning Microscopy PlatformFrom1 Dec 2025 → TodayFunding: BOF - scientific equipment program
- New nucleic acid based diagnostic probes and therapeutics via automated solid phase synthesisFrom1 Dec 2025 → TodayFunding: BOF - scientific equipment program
- Accurate and ultra-sensitive quantification of analytes using an Acquity UPLC - Xevo TQ-XS LC-MS triple quadrupole system.From1 Dec 2025 → TodayFunding: BOF - scientific equipment program
- High quality characterization of extracellular vesicles by nanoparticle tracking analysisFrom1 Dec 2025 → TodayFunding: BOF - scientific equipment program
- NanoClaws as a cure for feline immunodeficiency virus (FIV): constructing CD134-targeting CRISPR-Cas9 nanoparticles against FIVFrom1 Nov 2025 → TodayFunding: FWO Strategic Basic Research Grant
- Gluegel: a natural peptide-based hydrogel system for sustained release of therapeutic cargosFrom1 Nov 2025 → TodayFunding: IOF - technology concept exploration
- Integrative Omics Approaches to Unravel the Mechanisms of LNP-Mediated CRISPR Reprogramming in Tumor-Associated Regulatory T Cells (Tregs)From1 Nov 2025 → TodayFunding: FWO Strategic Basic Research Grant
Publications
1 - 10 of 2542
- MicroRNA profiling reveals a role for microRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease(2017)Published in: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEISSN: 1073-449XIssue: 1Volume: 195Pages: 43 - 56
- Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders : a retrospective cohort study(2021)Published in: SEMINARS IN ARTHRITIS AND RHEUMATISMISSN: 1532-866XIssue: 5Volume: 51Pages: 969 - 976
- MiR-223 is increased in lungs of patients with COPD and modulates cigarette smoke-induced pulmonary inflammation(2021)Published in: AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGYISSN: 1522-1504Issue: 6Volume: 321Pages: L1091 - L1104
- Synthesis of a 3'-C-ethynyl-β-D-ribofuranose purine nucleoside library : discovery of C7-deazapurine analogs as potent antiproliferative nucleosides(2018)Published in: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRYISSN: 0223-5234Volume: 157Pages: 248 - 267
- A microRNA-21–mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis(2021)Published in: SCIENCE TRANSLATIONAL MEDICINEISSN: 1946-6242Issue: 621Volume: 13
- Anti-IL-5 treatment, but not neutrophil interference, attenuates inflammation in a mixed granulocytic asthma mouse model, elicited by air pollution(2025)Published in: RESPIRATORY RESEARCHISSN: 1465-993XIssue: 1Volume: 26
- Impact of frailty on interpretability of spirometry : the Rotterdam study(2013)Volume: 42Number of pages: 1
- Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers(2009)Published in: ThoraxISSN: 0040-6376Issue: 1Volume: 64Pages: 26 - 32
- Different regulation of cigarette smoke induced inflammation in upper versus lower airways(2010)Published in: RESPIRATORY RESEARCHISSN: 1465-9921Issue: 1Volume: 11
- Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial(2013)Published in: ThoraxISSN: 0040-6376Issue: 4Volume: 68Pages: 322 - 329